Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milton Packer

European heart journal

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
European Heart Journal|September 2, 2025
Do obesity and visceral adiposity promote heart failure with reduced ejection fraction?Milton Packer
European Heart Journal|April 22, 2023
Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium-glucose cotransporter 2 inhibitorsMilton Packer
European Heart Journal|May 28, 2020
Longevity genes, cardiac ageing, and the pathogenesis of cardiomyopathy: implications for understanding the effects of current and future treatments for heart failureMilton Packer
European Heart Journal|August 8, 2019
What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?Milton Packer
European Heart Journal|May 14, 2019
Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillationMilton Packer
European Heart Journal|May 11, 2024
Identification of three mechanistic pathways for iron-deficient heart failureMilton Packer, Stefan D Anker, Javed Butler, et al.
European Heart Journal|July 15, 2005
Prognostic benefit of beta-blockers in patients not receiving ACE-InhibitorsHenry Krum, Steven Joseph Haas, Eric Eichhorn, et al.
European Heart Journal|December 8, 2021
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fractionJaved Butler, Milton Packer, Gerasimos Filippatos, et al.
European Heart Journal|June 10, 2022
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-PooledJoão Pedro Ferreira, Faiez Zannad, Javed Butler, et al.
European Heart Journal|December 30, 2021
Kidney function assessment and endpoint ascertainment in clinical trialsMuhammad Shahzeb Khan, George L Bakris, Milton Packer, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
European Heart Journal|September 2, 2025
Do obesity and visceral adiposity promote heart failure with reduced ejection fraction?Milton Packer
European Heart Journal|April 22, 2023
Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium-glucose cotransporter 2 inhibitorsMilton Packer
European Heart Journal|May 28, 2020
Longevity genes, cardiac ageing, and the pathogenesis of cardiomyopathy: implications for understanding the effects of current and future treatments for heart failureMilton Packer
European Heart Journal|August 8, 2019
What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?Milton Packer
European Heart Journal|May 14, 2019
Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillationMilton Packer
European Heart Journal|May 11, 2024
Identification of three mechanistic pathways for iron-deficient heart failureMilton Packer, Stefan D Anker, Javed Butler, et al.
European Heart Journal|July 15, 2005
Prognostic benefit of beta-blockers in patients not receiving ACE-InhibitorsHenry Krum, Steven Joseph Haas, Eric Eichhorn, et al.
European Heart Journal|December 8, 2021
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fractionJaved Butler, Milton Packer, Gerasimos Filippatos, et al.
European Heart Journal|June 10, 2022
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-PooledJoão Pedro Ferreira, Faiez Zannad, Javed Butler, et al.
European Heart Journal|December 30, 2021
Kidney function assessment and endpoint ascertainment in clinical trialsMuhammad Shahzeb Khan, George L Bakris, Milton Packer, et al.
Pageof 4